Keywords: alliance, stock, plummets, liquivent, disappoints, ards, trial

Alliance stock plummets as LiquiVent disappoints in ARDS trial

Article | 24 May 2001

Print This

Alliance Pharmaceutical Corp saw its share price fall 26% to $3.18 onMay 22 after the company announced preliminary results from a Phase II/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in